Paris-Based HealthTech Hublo Receives €40M Reinvestment From Revaia

The funding will support Hublo’s next development phase following its 2025 sale and extend investor support beyond the original investment timeline. This follows the closing of Revaia’s €250 million Growth II fund in 2025.

Antoine Loron co-founder and co-CEO of Hublo added “Revaia’s continued commitment to us is a continuation of a long term partnership built on trust and alignment. Their decision to reinvest alongside our new majority shareholder demonstrates their belief in our trajectory and strengthens the stability of our shareholder base for the next stage of our development.”

Founded in 2016, Hublo was created through the merger of Whoog and MedGo during the Covid crisis to tackle ongoing healthcare staffing shortages.

Read Also - UBEES Secures €8 Million Series A To Boost Beekeeping For Regenerative Agriculture

Its platform helps healthcare organisations manage recruitment, scheduling, internal mobility, and communication. By 2025, Hublo supported over 22,000 managers across 5,000 facilities, serving around 1 million professionals and saving users an average of 2.5 hours daily. Revaia, which acquired a major stake in 2021, has supported Hublo’s expansion and scaling efforts.

This growth allowed Hublo to quadruple its annual recurring revenue and achieve operational break-even earlier than expected.

In July 2025, Five Arrows, the alternative asset investment arm of Rothschild & Co, completed a strategic investment following a competitive process, marking the first exit for the Revaia Growth I fund.

Revaia’s reinvestment vehicle brings together investors from Europe, the UK, and the US, enabling both existing and new investors to partner with the new shareholder and Hublo’s management team.

Alice Albizzati, Founding Partner of Revaia, stated: “This reinvestment vehicle extends the support we have provided to Hublo since 2021 and reflects our confidence in the quality of the team and the company’s trajectory, while also allowing us to bring in new investors for the next phase of value creation.”

About Hublo

Hublo is a healthcare workforce management technology company that develops digital solutions to optimise staffing, recruitment, scheduling, and internal mobility for healthcare institutions. The company focuses on improving workplace environments for healthcare professionals, enhancing operational efficiency and supporting facilities in delivering high quality patient care through smarter workforce management tools.